Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Everolimus in Relapsed or Refractory Mantle Cell Lymphoma
NCT00516412Phase 2Completed
- Sponsor
- Swiss Group for Clinical Cancer Research
- Start
- Aug 2007
- Primary completion
- Jan 2010
- Modality
- Small Molecules
- Countries
- 3
01
Overview
A Phase 2 trial of everolimus in mantle cell lymphoma (MCL), sponsored by Swiss Group for Clinical Cancer Research. Started Aug 2007; status: completed.
02
Drugs
everolimus
03
Conditions
mantle cell lymphoma (MCL)
Beyond the preview
Go deeper on NCT00516412.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00516412.